Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Genetic heterogeneity of Borrelia burgdorferi in the United States.

Mathiesen DA, Oliver JH Jr, Kolbert CP, Tullson ED, Johnson BJ, Campbell GL, Mitchell PD, Reed KD, Telford SR 3rd, Anderson JF, Lane RS, Persing DH.

J Infect Dis. 1997 Jan;175(1):98-107.

PMID:
8985202
2.

Borrelia burgdorferi enzyme-linked immunosorbent assay for discrimination of OspA vaccination from spirochete infection.

Zhang YQ, Mathiesen D, Kolbert CP, Anderson J, Schoen RT, Fikrig E, Persing DH.

J Clin Microbiol. 1997 Jan;35(1):233-8.

3.

A fatal case of babesiosis in Missouri: identification of another piroplasm that infects humans.

Herwaldt B, Persing DH, Précigout EA, Goff WL, Mathiesen DA, Taylor PW, Eberhard ML, Gorenflot AF.

Ann Intern Med. 1996 Apr 1;124(7):643-50.

PMID:
8607592
4.

Novel Borrelia burgdorferi isolates from Ixodes scapularis and Ixodes dentatus ticks feeding on humans.

Anderson JF, Flavell RA, Magnarelli LA, Barthold SW, Kantor FS, Wallich R, Persing DH, Mathiesen D, Fikrig E.

J Clin Microbiol. 1996 Mar;34(3):524-9.

5.

Two geographically distinct isolates of Borrelia burgdorferi from the United States share a common unique ancestor.

Kolbert CP, Podzorski DS, Mathiesen DA, Wortman AT, Gazumyan A, Schwartz I, Persing DH.

Res Microbiol. 1995 Jun;146(5):415-24.

PMID:
8525058
6.

Infection with a babesia-like organism in northern California.

Persing DH, Herwaldt BL, Glaser C, Lane RS, Thomford JW, Mathiesen D, Krause PJ, Phillip DF, Conrad PA.

N Engl J Med. 1995 Feb 2;332(5):298-303.

7.

Detection of Borrelia burgdorferi DNA in museum specimens of Peromyscus leucopus.

Marshall WF 3rd, Telford SR 3rd, Rys PN, Rutledge BJ, Mathiesen D, Malawista SE, Spielman A, Persing DH.

J Infect Dis. 1994 Oct;170(4):1027-32.

PMID:
7930700
8.

Genetic stability of Borrelia burgdorferi recovered from chronically infected immunocompetent mice.

Persing DH, Mathiesen D, Podzorski D, Barthold SW.

Infect Immun. 1994 Aug;62(8):3521-7.

9.

Cultivation and phylogenetic characterization of a newly recognized human pathogenic protozoan.

Thomford JW, Conrad PA, Telford SR 3rd, Mathiesen D, Bowman BH, Spielman A, Eberhard ML, Herwaldt BL, Quick RE, Persing DH.

J Infect Dis. 1994 May;169(5):1050-6.

PMID:
8169390
10.

Detection of Babesia microti by polymerase chain reaction.

Persing DH, Mathiesen D, Marshall WF, Telford SR, Spielman A, Thomford JW, Conrad PA.

J Clin Microbiol. 1992 Aug;30(8):2097-103.

11.

Murine pharmacokinetics and metabolism of penclomedine [3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine, NSC 338720].

Reid JM, Mathiesen DA, Benson LM, Kuffel MJ, Ames MM.

Cancer Res. 1992 May 15;52(10):2830-4.

12.

Differences in N-acetylation of the experimental antitumor agent batracylin in the mouse and the rat.

Ames MM, Mathiesen DA, Reid JM.

Invest New Drugs. 1991 Aug;9(3):219-25.

PMID:
1783521
13.

High-performance liquid chromatographic assay and preclinical pharmacologic studies with the experimental antitumor agent batracylin.

Ames MM, Mathiesen DA.

J Chromatogr. 1989 Jul 21;491(2):488-94. No abstract available.

PMID:
2808633
14.

Preclinical pharmacology of the anthrapyrazole analog oxantrazole (NSC-349174, piroxantrone).

Frank SK, Mathiesen DA, Szurszewski M, Kuffel MJ, Ames MM.

Cancer Chemother Pharmacol. 1989;23(4):213-8.

PMID:
2924379
15.

High-performance liquid chromatographic assay for the experimental anticancer agent oxantrazole.

Frank SK, Mathiesen DA, Whitfield LR, Ames MM.

J Chromatogr. 1987 Aug 7;419:225-32.

PMID:
3667780

Supplemental Content

Loading ...
Support Center